TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
23/12/2022
Voltar para busca
Dado oficial do USPTO
YUNGSHIN
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
48
Atualização mais recente
23/12/2022
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5
Data de depósito
13/02/2008
Data de registro
01/02/2011
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
30/01/2021
Última transação
30/01/2021
Escritório responsável
United States Patent and Trademark Office
Código da situação
800
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
2010-01-00
Primeiro uso no comércio
2010-09-00
Código do desenho
3
Tipo de titular
03
Localização do titular
TACHIA TAICHUNG, TW
Examinador
HAN, DAWN
Unidade examinadora
L70
Localização atual
GENERIC WEB UPDATE
Titulares e representantes
Titulares
YUNG SHIN PHARM. IND. CO., LTD.
Representantes
Joe McKinney Muncy MUNCY, GEISSLER, OLDS & LOWE, PC
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Gastro-intestinal treatment preparations; cough drops; calcium supplement; analgesic preparations; oral analgesics; anti-inflammatories; anesthetics for surgical and non-surgical uses; sedatives; respiratory stimulants; pharmaceutical preparations to enhance digestion; antacids; nausea treatment preparation; diarrhea medications; laxatives; diuretic preparations; antibiotics; hemostatics; appetite suppressants for medical use; diet pills; medicated hair restoration lotions; hair growth stimulants; medicated scalp treatment cream; smoking cessation preparations; eczema treatment preparations; hemorrhoid treatment preparations; psoriasis treatment preparations; pharmaceutical preparations for the treatment of gout; pharmaceutical preparations for the treatment of arthritis; cough treatment preparations; highly caffeinated energy pills; breath-freshening chewing gum for medicinal purposes; blood plasma; antianginal preparation; acne treatment preparations; antipyretic analgesic; muscle relaxants; pharmaceutical anti-allergic preparations and substances; antidepressants; pharmaceutical preparations for the treatment of epilepsypharmaceutical preparations for the treatment of stomach ulcerspharmaceutical preparations for the treatment of tuberculosispharmaceutical preparations for the treatment of Parkinson's diseasepharmaceutical preparations for the treatment of rheumatismpharmaceutical preparations for the treatment of thrombosispharmaceutical preparations for the treatment of enuresispharmaceutical preparations for the treatment of hypertensionpharmaceutical preparations for the treatment of dermatosis; steroid ointments; human hormone for human use; pharmaceutical preparations for the prevention and treatment of disorders of the immune system; antihistamines; bronchodilators; pharmaceutical preparations for skin care; syringes sold filled with hyaluronic acid for use in arthroscopic surgeries; pharmaceutical preparations for the treatment of eye diseases and conditions; anti-cancer preparations; pharmaceutical preparations for treating diabetes; cholesterol reducers; hypnotics; preparations for treating colds; antiarrhythmics; oxytocics; expectorants; uterine contraction pharmaceutical preparations; contraceptives; athletes foot preparations; patches containing mosquito-repellent incenses for human use; vitamins; Chinese medicinesherb teas for medicinal purposespharmaceutical preparations for the treatment of cardiovascular diseases; pharmaceuticalsinducers of erections; hepatotonic agents for hepatological diseases; pharmaceutical preparations for the treatment of liver diseases; vaccines for human purposes; antivirals; ointments for pharmaceutical purposesnon-steroid anti-inflammatory ointments; ocular pharmaceuticalseye-wash; patches containing anti-inflammatories; pharmaceutical preparations for hemopoiesis; vitamin supplement in tablet form for use in making an effervescent beverage when added to water; pharmaceutical preparations for burn treatment; gelatin capsules sold empty for pharmaceuticals; suppositories; insect-repellents; pregnancy test kits for home use; diagnostic test kits consisting of diagnostic preparations for medical purposes; diagnostic kits consisting primarily of monoclonal antibodiesbuffersreagents for use in disease testing; ovulation test kits; mineral nutritional supplements; dietary supplements in capsules containing garlic extract; medicinal ganoderma lucidum extracts for medical purposes; food supplementsanti-oxidants; dietary supplements containing shark cartilage; vitamin and mineral supplements; dietary supplements in capsule forms containing shark liver oils; dietary supplements in capsule forms containing chitin extract; bread that is gluten-free to accommodate special medical and health conditions; dietary and nutritionally fortified food products adapted for medical use; dietary fiber powder as an additive for food products for restricted diet; dandruff shampoo
Publicações
Histórico de despachos e eventos da marca no USPTO.
48 publicações encontradas
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
23/12/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
23/12/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
23/12/2022
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
30/01/2021
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
30/01/2021
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
30/01/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
30/01/2021
E89R
TEAS SECTION 8 & 9 RECEIVED
06/11/2020
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
01/02/2020
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
06/12/2016
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
06/12/2016
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/12/2016
E815
TEAS SECTION 8 & 15 RECEIVED
26/09/2016
R.PR
REGISTERED-PRINCIPAL REGISTER
01/02/2011
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
28/12/2010
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
27/12/2010
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
21/12/2010
SUPC
STATEMENT OF USE PROCESSING COMPLETE
13/12/2010
IUAF
USE AMENDMENT FILED
10/12/2010
EISU
TEAS STATEMENT OF USE RECEIVED
10/12/2010
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
13/07/2010
EX2G
SOU EXTENSION 2 GRANTED
12/07/2010
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
12/07/2010
EXT2
SOU EXTENSION 2 FILED
14/06/2010
EEXT
SOU TEAS EXTENSION RECEIVED
14/06/2010
EX1G
SOU EXTENSION 1 GRANTED
07/12/2009
EXT1
SOU EXTENSION 1 FILED
07/12/2009
EEXT
SOU TEAS EXTENSION RECEIVED
07/12/2009
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
16/06/2009
PUBO
PUBLISHED FOR OPPOSITION
24/03/2009
NPUB
NOTICE OF PUBLICATION
04/03/2009
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
14/02/2009
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
14/02/2009
XAEC
EXAMINER'S AMENDMENT ENTERED
02/01/2009
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/01/2009
GNEA
EXAMINERS AMENDMENT E-MAILED
02/01/2009
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/01/2009
ACEC
AMENDMENT FROM APPLICANT ENTERED
12/12/2008
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/12/2008
ALIE
ASSIGNED TO LIE
12/12/2008
PAPER RECEIVED
01/12/2008
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
30/05/2008
GNRT
NON-FINAL ACTION E-MAILED
30/05/2008
CNRT
NON-FINAL ACTION WRITTEN
30/05/2008
DOCK
ASSIGNED TO EXAMINER
27/05/2008
MDSC
NOTICE OF DESIGN SEARCH CODE MAILED
20/02/2008
NWAP
NEW APPLICATION ENTERED
19/02/2008
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace YUNGSHIN ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.